About Axonal-Biostatem
Axonal-Biostatem is a company based in Nanterre (France) founded in 1989 was acquired by DOCAPOSTE in August 2023. Axonal-Biostatem offers products and services including Project Management, Monitoring, Data Management, Medical Writing, and Statistics. Axonal-Biostatem operates in a competitive market with competitors including Celgene, Syneos Health, Medelis WCCT Global, Emmes and Parexel, among others.
- Headquarter Nanterre, France
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Axonal-Biostatem
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Axonal-Biostatem
Axonal-Biostatem offers a comprehensive portfolio of products and services, including Project Management, Monitoring, Data Management, Medical Writing, and Statistics.
Handles full or partial clinical study projects.
Oversees progress of clinical trials and data collection.
Manages and analyzes data from health product studies.
Prepares reports and protocols for health authorities.
Provides statistical analysis for clinical research.
Funding Insights of Axonal-Biostatem
Detailed funding history for Axonal-Biostatem
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Axonal-Biostatem
Axonal-Biostatem has secured backing from 1 investor. Prominent investors backing the company include DOCAPOSTE.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Management consulting, health, IT, and digital services are provided.
|
Locked | Locked | Locked |
Investor details for Axonal-Biostatem
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Axonal-Biostatem
Investment portfolio details for Axonal-Biostatem
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Axonal-Biostatem
Detailed financials for Axonal-Biostatem
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Axonal-Biostatem Comparisons
Peer comparison for Axonal-Biostatem
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Axonal-Biostatem
Axonal-Biostatem operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celgene, Syneos Health, Medelis WCCT Global, Emmes and Parexel, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapies for cancer and inflammatory diseases are developed.
|
|
| Locked | Locked | Locked |
CRO clinical development services are provided by Syneos Health.
|
|
| Locked | Locked | Locked |
Full-service CRO expertise in influenza and oncology research is offered.
|
|
| Locked | Locked | Locked |
Outsourced contract research organization services are provided to clients.
|
|
| Locked | Locked | Locked |
Full-service clinical research organization services are provided globally by Parexel.
|
|
| Locked | Locked | Locked |
Global full-service CRO services are delivered in over 80 countries.
|
Detailed competitors of Axonal-Biostatem
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Axonal-Biostatem
Complete news archive for Axonal-Biostatem
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Axonal-Biostatem
Axonal-Biostatem was founded in 1989.
Axonal-Biostatem is headquartered in Nanterre, France.
Axonal-Biostatem was founded in 1989 and is headquartered in Nanterre, France. As a contract research organization, services are provided to pharmaceutical companies and medical device manufacturers for interventional and non-interventional studies. Clinical operations include project management, monitoring, data management, statistics, medical writing, vigilance management, and on-site support. Epidemiology services address disease onset factors, frequency, transmission modes, and progression patterns across Europe.
Axonal-Biostatem's top competitors include Emmes, Syneos Health and ClinChoice.
Axonal-Biostatem offers Project Management, Monitoring, Data Management, Medical Writing, and Statistics.
Axonal-Biostatem has 1 investor. Key investors include DOCAPOSTE.